CAMBRIDGE, Mass., Aug. 7 /PRNewswire-FirstCall/ -- Verenium Corporation (Nasdaq: VRNM), a leading developer of cellulosic ethanol technology and a pioneer in the development of high-performance specialty enzymes, announced today that Gerald M. Haines II, Executive Vice President, will present at the upcoming Canaccord Adams 28th Annual Global Growth Conference. The presentation is scheduled to begin at 10:30 a.m. ET on Thursday, August 14, and will take place at the InterContinental Hotel in Boston.
More information about this event, including a live webcast, may be accessed by visiting the "Investors" section of Verenium's website at http://www.verenium.com. A webcast replay will be available approximately one hour after the live webcast ends and will be accessible for one month following the conference.
Verenium Corporation is a leader in the development and
commercialization of cellulosic ethanol, an environmentally-friendly and
renewable transportation fuel, as well as high-performance specialty
enzymes for applications within the biofuels, industrial, and health and
nutrition markets. The Company possesses integrated, end-to-end
capabilities in pre-treatment, novel enzyme development, fermentation,
engineering, and project development and is moving rapidly to commercialize
its proprietary technology for the production of ethanol from a wide array
of feedstocks, including sugarcane bagasse, dedicated energy crops,
agricultural waste, and wood products. In addition to the vast potential
for biofuels, a multitude of large-scale industrial opportunities exist for
the Company for products derived from the production of low-cost,
|SOURCE Verenium Corporation|
Copyright©2008 PR Newswire.
All rights reserved